Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/02/031451
CTRI/2021/02/031451
Completed
Phase 1

Immunogenicity Assessment Extension Study OF Phase 1 PartOf Protocol NCOV 1002

Cadila Healthcare Ltd0 sites18 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Cadila Healthcare Ltd
Enrollment
18
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 4, 2021
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Subjects has completed the Phase 1 study (NCOV 1002\) in treatment arms 3 \& 4 (i.e. 2
  • •mg vaccine)
  • •2\. Willing to participate and provide informed consent for the study

Exclusion Criteria

  • •1\. Subjects who received another COVID vaccine after administration of last dose of
  • •vaccine in NCOV 1002\.
  • •2\. Subjects having history of positive documented COVID\-19 infection after completion
  • •of study in Phase I part of NCOV 1002

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a H1N1 Influenza Vaccine in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or Bone Marrow Transplantation and in Age-Matched Healthy Volunteers - Focetria TxVaccination for H1N1sw of immunocompromised adults who have undergone solid organ or bone marrow transplantation and of healthy adultsMedDRA version: 12.1Level: LLTClassification code 10022000Term: Influenza
EUCTR2009-017052-27-DEMedizinische Hochschule Hannover
Active, not recruiting
Not Applicable
A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a Seasonal Influenza Vaccine including H1N1 in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or Bone Marrow Transplantation and in Age-Matched Healthy Volunteers - Fluad Tx
EUCTR2010-022871-78-DEMedizinische Hochschule Hannover
Active, not recruiting
Not Applicable
Etude de phase II évaluant l'immunogénicité et la tolérance d'un vaccin inactivé non adjuvanté contre la grippe A/H1N1v chez la femme enceinte - PREFLUVACGrippe A H1N1MedDRA version: 12.0Level: LLTClassification code 10016797Term: Flu-like symptoms
EUCTR2009-016660-36-FRInserm
Active, not recruiting
Not Applicable
Etude de phase II évaluant l'immunogénicité et la tolérance d'un vaccin inactivé non adjuvanté contre la grippe A (H1N1) après transplantation rénale - TRANSFLUVAC
EUCTR2009-016659-23-FRInserm
Completed
Phase 4
to evaluate the Immunogenicity and Safety of Typbar-TCV® in Adults
CTRI/2019/10/021823Bharat Biotech International Ltd300